• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23369 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     National Institute for Health and Care Excellence (NICE) Dimethyl fumarate for treating moderate to severe plaque psoriasis. NICE technology appraisal guidance 475
2017     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Primary section - surgical techniques and reimbursement]
2017     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Cannabinoids in patients with autism spectrum disorders]
2017     HAYES, Inc. Afirma thyroid FNA analysis (Veracyte)
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use, in Québec, of probiotics in the prevention of Clostridium difficile-associated diarrhea in hospitalized patients on antibiotic therapy]
2017     National Institute for Health and Care Excellence (NICE) Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer. NICE technology appraisal guidance 476
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Transanal endoscopic microsurgery (tem) and transanal minimally invasive surgery (tamis) for the treatment of rectal lesions]
2017     HAYES, Inc. AlloSure (CareDx)
2017     National Institute for Health and Care Excellence (NICE) Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma. NICE technology appraisal guidance 478
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intensity-modulated radiation therapy for breast cancer]
2017     HAYES, Inc. Cologuard (Exact Sciences Corp.)
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: chemoembolization for unresectable liver metastases according to the primary origin and chemoperfusion for advanced pancreatic cancer]
2017     National Institute for Health and Care Excellence (NICE) Reslizumab for treating severe eosinophilic asthma. NICE technology appraisal guidance 479
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Invasive electroencephalography monitoring with depth electrodes in presurgical assessment of patients with refractory epilepsy]
2017     HAYES, Inc. GeneStrat (Biodesix Inc.)
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: comparison of cervical cancer screening strategies involving the human papillomavirus screening test (HPV test) or gynecological cytology (Pap test)]
2017     National Institute for Health and Care Excellence (NICE) Tofacitinib for moderate to severe rheumatoid arthritis. NICE technology appraisal guidance 480
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Gadoxetic acid-enhanced magnetic resonance imaging to diagnose focal liver lesions]
2017     HAYES, Inc. OVA1 (ASPiRA Labs)
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge in support of the decision to integrate new endobronchial ultrasound (EBUS) services in Québec hospitals]
2017     National Institute for Health and Care Excellence (NICE) Immunosuppressive therapy for kidney transplant in adults. NICE technology appraisal guidance 481
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intradialytic parenteral nutrition in patients with chronic kidney conditions]
2017     HAYES, Inc. ThyGenX and ThyraMIR (Interpace Diagnostics)
2017     National Institute for Health and Care Excellence (NICE) Immunosuppressive therapy for kidney transplant in children and young people. NICE technology appraisal guidance 482
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Whole exome sequencing in patients with undiagnosed neurological diseases]
2017     HAYES, Inc. Comparative effectiveness of bioresorbable vascular scaffold stents versus other drug-eluting stents for the treatment of coronary artery disease
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: fibrinolysis in ST-segment elevation acute myocardial infarction]
2017     National Institute for Health and Care Excellence (NICE) Sarilumab for moderate to severe rheumatoid arthritis. NICE technology appraisal guidance 485
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Posterior tibial nerve stimulation in overactive bladder]
2017     HAYES, Inc. Comparative effectiveness of endovenous radiofrequency ablation versus conventional surgery for symptomatic varicose veins: a review of reviews
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal usage guide: cellulitis in adults and children]
2017     National Institute for Health and Care Excellence (NICE) Aflibercept for treating choroidal neovascularisation. NICE technology appraisal guidance 486
2017     NIHR Health Technology Assessment programme Managing diabetes in people with dementia: a realist review
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Diode laser vaporization in benign prostatic hyperplasia]
2017     HAYES, Inc. Comparative effectiveness of skin substitutes for chronic foot ulcers in adults with diabetes mellitus: a review of reviews
2017     National Institute for Health and Care Excellence (NICE) Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours. NICE technology appraisal guidance 488
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Motorized Intramedullary nails for bone lenghtening in achondroplasia or hypochondropasia]
2017     HAYES, Inc. Comparative effectiveness of skin substitutes for chronic venous leg ulcers in adults: a review of reviews
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: maintaining a stockpile of influenza antivirals in preparation for a flu pandemic]
2017     National Institute for Health and Care Excellence (NICE) Vismodegib for treating basal cell carcinoma. NICE technology appraisal guidance 489
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dimethyl fumarate in multiple sclerosis: Comparison among different commercially available trademarks in Argentina]
2017     HAYES, Inc. Comparative effectiveness review of antimicrobial versus conventional sutures
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: update of proton radiation therapy indications in oncology]
2017     National Institute for Health and Care Excellence (NICE) Naltrexone–bupropion for managing overweight and obesity. NICE technology appraisal guidance 494
2017     NIHR Health Technology Assessment programme Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic fixation for spine degenerative diseases]
2017     HAYES, Inc. Comparative effectiveness review of endoscopic therapy for gastroesophageal reflux disease
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: organization of the continuum and provision of services to children aged 2 to 9 years with specific language impairment]
2017     National Institute for Health and Care Excellence (NICE) Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer. NICE technology appraisal guidance 496
2017     NIHR Health Technology Assessment programme The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Autologous lymph node transfer for lymphedema secondary to breast cancer]
2017     HAYES, Inc. Comparative effectiveness review of hyaluronic acid for knee osteoarthritis: a review of reviews
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of introducing a pathogen inactivation process for labile blood products in Quebec]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Fractional exhaled nitric oxide measurement in patients with asthma and chronic cough]
2017     HAYES, Inc. Comparative effectiveness review of minimally invasive total hip arthroplasty
2017     Norwegian Institute of Public Health (NIPH) Assessment of conductive education for children and adolescents with brain damage: a health technology assessment
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Negative pressure therapy in chronic wounds]
2017     HAYES, Inc. Comparative effectiveness review of multilevel artificial disc replacement for cervical degenerative disc disease
2017     Norwegian Institute of Public Health (NIPH) Digital Breast Tomosynthesis with Hologic 3D mammography Selenia Dimensions System for use in breast cancer screening
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Portraits describing pharmacological and non-pharmacological interventions for attention deficit hyperactivity disorder (ADHD) in Quebecers 25 years of age and under]
2017     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline on the management of vasomotor and vaginal symptoms associated with menopause and postmenopause]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Nintedanib in lung cancer]
2017     HAYES, Inc. Comparative effectiveness review of nonirradiated allografts for primary anterior cruciate ligament reconstruction
2017     Norwegian Institute of Public Health (NIPH) Sutureless aortic valve replacement for treatment of severe aortic stenosis: A single technology assessment of Perceval sutureless aortic valve
2017     Andalusian Health Technology Assessment Area (AETSA) [Guideline for the elaboration of recommendations and appropriate use criteria in health technologies]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Genetic sequencing panel for motor-sensory hereditary neuropathy diagnosis]
2017     HAYES, Inc. Comparative effectiveness review of platelet-rich plasma for knee osteoarthritis: a review of reviews
2017     Norwegian Institute of Public Health (NIPH) FreeStyle Libre Flash Glucose Self-Monitoring System: A Single-Technology Assessment
2017     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guidelines for hemotherapy. Brief report]
2017     NIHR Health Technology Assessment programme Researching outcomes from forensic services for people with intellectual or developmental disabilities: a systematic review, evidence synthesis and expert and patient/carer consultation
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [3D Echocardiography in heart valve diseases]
2017     HAYES, Inc. Comparative effectiveness review of platelet-rich plasma for tendinopathies or ligament injuries of the knee
2017     Norwegian Institute of Public Health (NIPH) Assessment of four intensive habilitation programs for children and adolescents with brain damage – a health technology assessment
2017     Andalusian Health Technology Assessment Area (AETSA) [Neonatal hypoacusis screening]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Nusinersen (Spinraza®) in spinal muscular atrophy]
2017     HAYES, Inc. Comparative effectiveness review of platelet-rich plasma for treatment of lateral epicondylitis: a review of reviews
2017     Andalusian Health Technology Assessment Area (AETSA) [Faecal microbiota transplant for recurrent clostridium difficile infection. Up-date]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Olaparib in ovarian cancer]
2017     HAYES, Inc. Comparative effectiveness review of pyrocarbon proximal interphalangeal and metacarpophalangeal joint implants
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report on optimal antipsychotic use and the nonpharmacological management of the behavioural and psychological symptoms of dementia in people with major neurocognitive disorders living in residential and long-term care centers]
2017     NIHR Health Technology Assessment programme Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Nivolumab for the treatment of advanced melanoma]
2017     HAYES, Inc. Comparative effectiveness review of total ankle replacement: a review of reviews
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report and optimal usage guide: immunoglobulins in neurology]
2017     Andalusian Health Technology Assessment Area (AETSA) [Efficacy, effectiveness and safety of physiotherapy in patients with multiple sclerosis. Rapid response]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Ceritinib in lung cancer]
2017     HAYES, Inc. Digital breast tomosynthesis for breast cancer diagnosis and screening
2017     Andalusian Health Technology Assessment Area (AETSA) [Rapid response: Effectiveness and safety of hyperthermia in combination with radiation therapy and/or chemotherapy in the treatment of breast, cervix and rectum cancer]
2017     HAYES, Inc. Functional electrical stimulation for rehabilitation following spinal cord injury
2017     HAYES, Inc. Hyperbaric oxygen therapy for diabetes-related foot ulcers: a review of reviews
2017     National Institute for Health and Care Excellence (NICE) Endobronchial valve insertion to reduce lung volume in emphysema. NICE interventional procedures guidance 600
2017     NIHR Health Technology Assessment programme A multicentre, randomised controlled trial of position during the late stages of labour in nulliparous women with an epidural: clinical effectiveness and an economic evaluation (BUMPES)
2017     NIHR Health Technology Assessment programme A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE)
2017     HAYES, Inc. Impact of preoperative supervised weight loss programs on bariatric surgery outcomes
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Obstetric MRI
2017     National Institute for Health and Care Excellence (NICE) Transcutaneous microwave ablation for severe primary axillary hyperhidrosis. NICE interventional procedures guidance 601
2017     NIHR Health Technology Assessment programme Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation
2017     HAYES, Inc. Ketamine as an adjunct to electroconvulsive therapy for treatment-resistant depression
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vertebroplasty for severely painful osteoporotic vertebral fractures of less than 6 weeks duration